Relationship between pharmacokinetic profile of subcutaneously administered alemtuzumab and clinical response in patients with chronic lymphocytic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/21330330

Download in:

View as

Triples

General Info

PMID
21330330